（蔡淑敏/摄） 这将成为美的集团年内第三次回购。3月29日，美的集团曾发布公告称，公司将通过集中竞价交易回购A股股份，计划金额50亿至100亿元；4月8日，再 次预告将以同类方式回购A股股份15亿至30亿元，目前，前者交易尚未开始；后者已支付金额9亿元，累计回购股份1218.88万股，占总股本的0.16%。 梳理公司近年来的资本运作可见，美的集团在股份回购方面表现积极。2021年2月，公司推出当时被称为A股最大规模回购计划，拟以不超过140亿元回 购5000万至1亿股。该计划不到2个月宣告完成，截至4月2日即以86.64亿元完成1亿股回购。同年5月，美的集团再度启动回购，拟投入25亿至50亿元，并于 当年8月3日全额完成50亿元回购。2022年3月，公司再次推出25亿至50亿元回购方案，于2023年3月以26.37亿元实施完毕。据不完全统计，自2021年以来， 美的集团抛出的回购计划金额最高达370亿元。 值得一提的是，不只美的集团，白电三大巨头之一的海尔智家也在回购。4月2日晚间，海尔智家（600690.SH）发布回购方案报告书透露，拟在一年内 斥资不超过20亿元且不低于10亿元回购A股股票，回购价不超过4 ...

沪指6月17日下跌0.04%，申万所属行业中，今日上涨的有14个，涨幅居前的行业为煤炭、公用事业， 涨幅分别为0.89%、0.82%。家用电器行业今日上涨0.48%。跌幅居前的行业为医药生物、美容护理，跌 幅分别为1.44%、1.24%。 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 000333 | 美的集团 | 1.12 | 0.47 | 29092.48 | | 603215 | 比依股份 | 6.13 | 17.67 | 9597.08 | | 600690 | 海尔智家 | 2.01 | 0.68 | 8985.90 | | 603579 | 荣泰健康 | 10.01 | 6.24 | 4534.79 | | 300342 | 天银机电 | 2.99 | 8.92 | 4486.90 | | 002402 | 和而泰 | 1.63 | 4.33 | 3637.89 | | 300403 | 汉宇集团 | 1.06 | 5.44 | 1730.93 | | 300911 | 亿田智能 | ...

21世纪经济报道记者 翁榕涛 广州报道 "不差钱"的美的集团（000333.SZ）再次抛出百亿元回购方案。 6月16日，美的集团公告称，计划以50亿元至100亿元的金额回购股票，70%以上股份用于注销。 据21世纪经济报道记者不完全统计，自2021年以来，美的集团抛出的回购计划金额最高达370亿元。 Wind数据显示，美的集团自2015年以来，累计回购超过5亿股股票，占目前流通股的7%，累计回购金 额超过291亿元，若叠加此次回购方案，有望问鼎A股"回购王"。 此前A股"回购王"是另一家电企业格力电器（000651.SZ），数据显示自2021年进行了4次回购，累计回 购6.17亿股，累计回购金额近300亿元。 本就是"分红优等生"的美的，今年在分红和回购上更加大方，若按照回购方案上限100亿计算，今年美 的分红加回购金额的总额达到367亿元，已经接近2024年利润的95%，也就是去年绝大部分利润都拿出 来回馈股东和市场。 公告显示，美的集团此次回购金额不超过100亿元，不低于50亿元。回购所需资金来源于公司自有资金 及/或股票回购专项贷款。回购的股份当中，70%以上将用于注销以减少注册资本，剩余部分用于股权 ...

Core Viewpoint - Goldman Sachs' newly selected list of "Top 10 Private Enterprises in China" has garnered significant market attention, highlighting the vitality of China's private economy and reflecting five core trends in industrial development: technological innovation, domestic demand-driven growth, globalization, consumption upgrades, and corporate governance optimization [1] Group 1: Company Overview - The selected 10 companies include Tencent, Alibaba, Xiaomi, BYD, Meituan, NetEase, Midea, Hengrui Medicine, Ctrip, and Anta, representing a complete ecosystem of China's new economy [3] - Tencent and Alibaba dominate the digital economy, with Tencent's fintech and enterprise services accounting for 34% of its revenue, while Alibaba's cloud computing business has achieved profitability for eight consecutive quarters [3] - BYD and Xiaomi serve as the dual engines of China's intelligent manufacturing, with BYD surpassing Tesla in electric vehicle sales and Xiaomi holding a 14.1% global market share in smartphones [3] Group 2: Financial Performance - The average compound annual growth rate of revenue for these 10 companies over the past five years is 19.8%, significantly outpacing other constituents of the MSCI China Index [5] - Meituan's takeout business shows stable growth, with new business losses narrowing to 4.8 billion yuan, while NetEase's overseas gaming revenue exceeds 35%, showcasing its strong cross-cultural operational capabilities [5] - The average R&D intensity of the top 10 companies is 8.2% of revenue, with Hengrui Medicine's R&D investment reaching 28%, indicating a strong commitment to future growth [5] Group 3: Valuation Insights - The average price-to-earnings ratio of these companies is 16 times, representing a 20% discount compared to their historical average [7] - Midea Group's dividend yield has risen to 4.5%, while Anta Sports' operating cash flow increased by 32% year-on-year, and Ctrip's total bookings have recovered to 1.3 times the level of 2019 [7] - Compared to U.S. tech giants, the PEG ratio of China's top 10 shows significant advantages, particularly in the commercialization of AI, with Alibaba's Tongyi Qianwen and Tencent's Hunyuan large model entering large-scale application phases [7] Group 4: Policy Environment - The top 10 companies benefit from favorable national policies, including the introduction of digital economy promotion regulations, continued tax exemptions for new energy vehicle purchases until 2027, and the expansion of green channels for innovative drug and medical device approvals [9] - The expansion of the Hong Kong Stock Connect and the reform of the A-share registration system have improved the financing environment for private enterprises, with estimated annual incremental capital inflows exceeding 80 billion yuan through these channels [9] Group 5: Future Outlook - These leading enterprises are expected to continue driving industrial transformation, with Tencent exploring virtual and real integration, Alibaba repositioning in the AI large model era, BYD's intelligent transformation, and Meituan's commercialization of drone delivery [11] - As the demand for wealth management among Chinese residents surges, these quality assets are poised to become key targets for both domestic and foreign capital allocation [11] Group 6: Notable Exclusion - Notably, Huawei is absent from Goldman Sachs' list of "Top 10 Private Enterprises in China" as it is not a publicly listed company, which is a criterion for inclusion [13]

第 652 期 2025-06-17 焦点事件 巴奴递表港交所！一季度营收7.087亿元 6月16日晚间，巴奴国际控股有限公司向港交所提交上市申请书，联席保荐人为中金公司、招银国际。 披露文件显示，2024年一季度及2025年一季度，公司分别实现收入5.639亿元、7.087亿元，同期经调整 净利润分别为人民币5750万元、7670万元。截至最后实际可行日期，巴奴的直营门店网络覆盖全国39个 城市，门店数量达到145家，较2021年末增长74.7%。 创新药赛道，迎重磅利好！ 6月16日，国家药品监督管理局发布公告称，为落实《国务院办公厅关于全面深化药品医疗器械监管改 革促进医药产业高质量发展的意见》有关要求，支持创新药研发，国家药监局在开展优化创新药临床试 验审评审批试点工作经验基础上，组织起草了《关于优化创新药临床试验审评审批有关事项的公告（征 求意见稿）》，现向社会公开征求意见。 其中提到，为进一步支持以临床价值为导向的创新药研发，提高临床研发质效，对符合要求的创新药临 床试验申请在30个工作日内完成审评审批。药物临床试验申请审评审批30日通道支持国家重点研发品 种，鼓励全球早期同步研发和国际多中心临床 ...

Group 1: Market Performance - The easing of Middle East conflict concerns has led to a rebound in U.S. stocks, with the Dow Jones up 0.75%, S&P 500 up 0.94%, and Nasdaq up 1.52% [1] - Chip stocks rose by 3%, with AMD increasing nearly 9%, while airline stocks also saw significant rebounds, with United Airlines up over 6% [1] - Chinese concept stocks outperformed the market, with the Chinese concept index rebounding over 2%, and RGC (Regenerative Medicine) soaring over 280% [1] Group 2: Economic Indicators - Following news of Iran's willingness to resume negotiations, the U.S. dollar index hit a daily low, while crude oil and gold prices experienced significant drops, with crude oil falling 10% from its daily high [1] - U.S. Treasury yields hit a daily low but later rebounded after a stable auction of 20-year Treasury bonds [2] Group 3: Industry Developments - The National Medical Products Administration of China is seeking public opinion on optimizing the review and approval process for innovative drug clinical trials, proposing to reduce the review period from 60 days to 30 days [4] - Guangdong Province has issued an action plan to accelerate the high-quality development of the nuclear medicine industry, aiming to cultivate 3-5 leading enterprises by 2030 [5] - Job demand for humanoid robots has surged by 409% year-on-year in the first five months of this year, according to Zhilian Recruitment [6] Group 4: Stock Market Insights - The Shanghai Composite Index fell below the critical support level of 3380 points but found support in the 3350-3360 range, while the ChiNext Index rebounded after hitting the 2030 support level [8] - The military industry sector has shown strong performance due to the Paris Air Show and geopolitical tensions, while the innovative drug sector has experienced fluctuations [8] Group 5: New Policies and Initiatives - Starting July 1, Dalian and Hubei provinces will implement a tax refund policy for overseas travelers, expanding the network of tax refund stores significantly [11] - The Chinese Ministry of Finance announced a reduction in the minimum purchase amount for tax refunds from 500 yuan to 200 yuan, enhancing the convenience of the refund process [11] Group 6: Company Announcements - Xiaomi is set to launch its new SUV model, the YU7, at the end of June, which emphasizes long battery life, intelligent driving, and ecosystem connectivity [12] - The company aims to replicate its success in the smartphone industry within the automotive sector by leveraging its large user base and innovative capabilities [12]

高盛相对更为看好占据行业头部的大型民营企业 ，并认为中国民营企业领域的行业集中度将进一步 上升。 刘劲津在报告中写道："我们预期的市场格局变化和结构性趋势使我们相信，民营企业领域的市场 （市值）集中度将会上升。" 来源|财联社 近日，高盛首席中国股票策略师刘劲津发布名为 《中国民营企业的回归：潮流已经逆转》 的研究 报告。刘劲津指出，在各种宏观、政策和微观因素驱动下，中国民营企业的中期投资前景正在改 善。 高盛还仿效美股"七巨头"，列出了中国"十巨头"，即高盛特别看好的十大中国民营上市公司。高盛 预计，中国民营企业领域在股市的集中度将上升，"十巨头"有望从中获得进一步的增长动力。 01 市场集中度有望上升 刘劲津列举了以下八点原因： 1.在全球主要股票市场中，中国是市场集中度最低的国家——前十大公司（包括国企）占整个市场 市值的17%，而美国为33%，新兴市场（除中国外）为30%。 2. 近年来，中国的反垄断和并购框架变得更加透明，这对民营企业的有机增长和收购式增长来说是 个好兆头； 3.现有行业领导者可能会进一步增加市场份额和盈利能力； 4.根据高盛分析，一些龙头企业已经在各自行业的利润池、资本支出和研发方 ...

证券代码：000333 证券简称：美的集团 公告编号：2025-054 美的集团股份有限公司 关于以集中竞价方式回购公司 A 股股份方案的报告书 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1、回购股份类别：公司发行的A股股票。 2、回购金额及来源：不超过100亿元，不低于50亿元。本次回购所需资金来 源于公司自有资金及/或股票回购专项贷款。 3、回购价格：不超过100元/股。 4、回购数量：在回购股份价格不超过100元/股的条件下，按回购金额上限 100亿元测算，预计回购股份数量不低于100,000,000股，约占公司目前已发行总 股本的1.30%；按回购金额下限50亿元测算，预计回购股份数量不低于50,000,000 股，约占公司目前已发行总股本的0.65%，具体回购股份的数量以回购期满时实 际回购的股份数量为准。 5、回购用途：本次回购股份将用于注销并减少注册资本及实施股权激励计 划及/或员工持股计划，其中70%及以上回购股份将用于注销并减少注册资本。 6、回购期限：自股东会审议通过回购股份方案之日起12个月内。 7、截至本公告披露日 ...

美的集团（000333）公告，公司拟以集中竞价方式回购股份，回购金额不超过100亿元且不低于50亿 元，资金来源为自有资金及/或股票回购专项贷款。回购价格不超过100元/股，预计回购股份数量不低 于5000万股且不超过1亿股，约占公司目前已发行总股本的0.65%-1.30%。本次回购股份将用于注销并减 少注册资本及实施股权激励计划及/或员工持股计划，其中70%及以上回购股份将用于注销并减少注册 资本。回购期限为自股东会审议通过回购股份方案之日起不超过十二个月。 ...

见闻 618 · 活动进行 中 新人 9元 解锁 VIP 长按 图片 识别 二维码 进入主会场 高盛最新发布的三部曲研究报告显示，中国正在酝酿属于自己的"七姐妹"。 据追风交易台消息，高盛策略团队近日发布重磅研究， 首次提出高中国"民营十巨头"（Chinese Prominent 10）的概念，将腾讯、阿里巴巴、小米等十家民 营企业巨头直接对标美国"美股七姐妹"（Magnificent 7）， 意在挖掘中国股市中具备长期霸主潜力的核心资产。 报告显示，这十家企业横跨科技、消费、汽车等高增长领域，代表了中国经济的"新动能"——人工智能、自主创新、全球化扩张及服务消费升级。公司总市值 高达1.6万亿美元，占据MSCI中国指数42%的权重，预计未来两年盈利复合年增长率达13%。 高盛认为，中国"民营十巨头"具备类似"美股七姐妹"的市场主导潜力，可能在未来进一步提升中国股市的集中度，改变投资者对中国资产的认知。 "民营十巨头"覆盖多个行业，增长潜力与合理定价并存 高盛筛选出的"民营十巨头"包括： 腾讯（市值6010亿美元）、阿里巴巴（2890亿美元）、小米（1460亿美元）、比亚迪（1210亿美元）、美团（1020亿 ...